[en] For 318 patients in 8 different Belgian hospitals, the entire skin-dose distribution was mapped using a grid of 70 thermoluminescence dosimeters per patient, allowing an accurate determination of the maximum skin dose (MSD). Dose-area product (DAP) values, exposure parameters and geometry, together with procedure, patient and cardiologist characteristics, were also registered. Procedures were divided into two groups: diagnostic procedures (coronary angiography) and therapeutic procedures (dilatation, stent, combined procedures (e.g. coronary angiography + dilatation + stent)). The mean value of the MSD was 0.310 Gy for diagnostic and 0.699 Gy for therapeutic procedures. The most critical projection for receiving the MSD is the LAO90 (left anterior oblique) geometry. In 3% of cases, the MSD exceeded the 2 Gy dose threshold for deterministic effects. Action levels in terms of DAP values as the basis for a strategy for follow-up of patients for deterministic radiation skin effects were derived from measured MSD and cumulative DAP values. Two DAP action levels are proposed. A first DAP action level of 125 Gy cm(2) corresponding to the dose threshold of 2 Gy would imply an optional radiopathological follow-up depending on the cardiologist's decision. A second DAP action level of 250 Gy cm(2) corresponding to the 3 Gy skin dose would imply a systematic follow-up. Dose reference levels - 71.3 Gy cm(2) for diagnostic and 106.0 Gy cm(2) for therapeutic procedures - were derived from the 75 percentile of the DAP distributions. As a conclusion, we propose that total DAP is registered in patient's record file, as it can serve to improve the follow-up of patients for radiation-induced skin injuries.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Bogaert, E.
Bacher, K.
Lemmens, K.
Carlier, M.
Desmet, W.
De Wagter, X.
Djian, D.
Hanet, C.
Heyndrickx, G.
Legrand, Victor ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie
Taeymans, Y.
Thierens, H.
Language :
English
Title :
A large-scale multicentre study of patient skin doses in interventional cardiology: dose-area product action levels and dose reference levels.
Shope TB. Radiation-induced skin injuries from fluoroscopy. Radiographics 1996;16:1195-9.
Wagner LK, Eifel PJ, Geise RA. Potential biological effects following high X-ray dose interventional procedures. J Vasc Interv Radiol 1994;5:71-84.
FDA Public Health Advisory. Avoidance of serious X-ray- induced skin injuries to patients during fluoroscopically- guided procedures. http://www.fda.gov/cdrh/fluor.html. 1994.
Koenig TR, Wolff D, Mettler FA, Wagner LK. Skin injuries from fluoroscopically guided procedures: part I, characteristics of radiation injury. AJR Am J Roentgenol 2001;177:3-11.
Koenig TR, Mettler FA, Wagner LK. Skin injuries from fluoroscopically guided procedures: part 2, review of 73 cases and recommendations for minimizing dose delivered to patient. AJR Am J Roentgenol 2001;177:13-20.
Kuon E, Glaser C, Dahm JB. Effective techniques for reduction of radiation dosage to patients undergoing invasive cardiac procedures. Br J Radiol 2003;76:406-13.
Hirshfeld JW, Balter SD, Brinker JA, Kern MJ, Klein LW, Lindsay BD et al. ACCF/AHA/HRS/SCAI clinical competence statement on physician knowledge to optimize patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures - a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. Circulation 2005;111:511-32.
ICRP. Recommendations of the International Commission on Radiological Protection. Publication 85: Avoidance of radiation injuries from medical interventional procedures. Ann. ICRP. Oxford, UK: Pergamon Press 2000: 30.
Vaño E, Gonzalez L, Ten JI, Fernandez JM, Guibelalde E, Macaya C. Skin dose and dose-area product values for interventional cardiology procedures. Br J Radiol 2001;74:48-55.
Neofotistou V, Karoussou A, Lobotesi H, Hourdakis K. Patient dosimetry during interventional cardiology procedures. Radiat Prot Dosim 1998;80:151-4.
Suzuki S, Furui S, Kohtake H, Yokoyama N, Kozuma K, Yamamoto Y, et al. Radiation exposure to patient's skin during percutaneous coronary intervention for various lesions, including chronic total occlusion. Circ J 2006; 70:44-8.
Marshall NW, Chapple CL, Kotre CJ. Diagnostic reference levels in interventional radiology. Phys Med Biol 2000; 45:3833-46.
Grosswendt B. Conversion coefficients for calibrating individual photon dosimeters in terms of dose equivalents defined in an ICRU tissue cube and PMMA slabs. Radiat Prot Dosim 1990;32:219-31.
Olson CL. Comparative robustness of 6 tests in multivariate- analysis of variance. J Am Stat Assoc 1974;69:894-908.
Research Development Core Team. A language and environment for statistical computing. Research Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0; http://www.R-project.org. 2008.
Kuon E, Dahm JB, Empen K, Robinson DM, Reuter G, Wucherer M. Identification of less-irradiating tube angula- tions in invasive cardiology. J Am Coll Cardiol 2004;44:1420-8.
Zorzetto M, Bernardi G, Morocutti G, Fontanelli A. Radiation exposure to patients and operators during diagnostic catheterization and coronary angioplasty.Catheter Cardiovasc Diagn 1997;40:348-51.
Hansson B, Karambatsakidou A. Relationships between entrance skin dose, effective dose and dose area product for patients in diagnostic and interventional cardiac procedures. Radiat Prot Dosim 2000;90:141-4.
van de Putte S, Verhaegen F, Taeymans Y, Thierens H. Correlation of patient skin doses in cardiac interventional radiology with dose-area product. Br J Radiol 2000;73:504-13.
Vaño E, Gonzalez L, Fernandez JM, Guibelalde E. Patient dose values in interventional radiology. Br J Radiol 1995;68:1215-20.
Vaño E, Goicolea J, Galvan C, Gonzalez L, Meiggs L, Ten JI, et al. Skin radiation injuries in patients following repeated coronary angioplasty procedures. Br J Radiol 2001;74:1023-31.
Padovani R, Novario R, Bernardi G. Optimisation in coronary angiography and percutaneous transluminal coronary angioplasty. Radiat Prot Dosim 1998;80:303-6.
Karambatsakidou A, Tornvall P, Saleh N, Chouliaras T, Lofberg P, Fransson A. Skin dose alarm levels in cardiac angiography procedures: is a single DAP value sufficient? Br J Radiol 2005;78:803-9.
Neofotistou V, Vaño E, Padovani R, Kotre J, Dowling A, Toivonen M, et al. Preliminary reference levels in interven-tional cardiology. Eur Radiol 2003;13:2259-63.
Lobotessi H, Karoussou A, Neofotistou V, Louisi A, Tsapaki V. Effective dose to a patient undergoing coronary angiography. Radiat Prot Dosim 2001;94:173-6.
European Commission Council Directive of 30 June 1997 (97/43/Euratom) on Health Protection of Individuals against the Dangers of Ionising Radiation in relation to Medical Exposure. Official J Eur Commun 1997;180:22-7.